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ABSTRACT 
The nitrogen mustard mechlorethamine (:--;H,) i~ a potent contuet allergen, sensitizing 
up to 7!')', of those exposed. An attempt was made to pre\enl allergic contact sensitization, 
i.e. to induce specific immunologic tolerance. in 9 patients who were to he treated topically 
with , H 2 for widespread and persistent psoriasis. Fourteen and 7 days before the first top-
ical application of ;\JH 2, they were given intravenous injections of :l mg ~H2• Topical treat-
ment with N H 2 was repeat eel weeki~· for 8 to 10 weeks in I patients and daily for about 4 
weeks in 5 patient!.. Two of the 9 patients became contact allerj!ic to :--:H 2• Despite the 
apparent failure to induce tolerance. further trials in a lnrj!er series of patients and trials 
'' ith different "to! erogenic" schedules and different topical lreatment ·chedules are 
warranted. 
It is 4:3 vear... smce Frei (ll ftr::;t published in 
"estigations 111 man and Sulzberger (~) in labora-
tory an1mals which showed that it is possible to 
specifically mterfere w1th the induction of de-
layed allerg1c contact sens1tizat 10n. The technic 
used was the intra\'enous inject ion of the allergen 
some time before application of a senc;itizing do!'.e 
of the !.ame allergen to the skin. The voluminou!; 
literature on the subject of induction of specific 
immunolo~ie tolerance. which has appeared 
during the intervening years. has provided a 
broad experimental background for possible prac-
tical application of the principle of prevention of 
sensitization. We refer particularly to the work ol 
Chase (:ll, Haer, Rosenthal and Hagel (4). 
DeWeck and Fre~ (5). Lowney (6) and Macher 
and Chase (7). Despite these !.Cientific develop-
ments. the !'.pecifit prevention of allergic contact 
sensitizatiOn (i.e .. the induction of specific immu 
nologic tolerance) remains an important unsolved 
problem in the field of 1m munology. as applied w 
the practice of dermatology. 
There are probably several reasons why the 
knowledge gained through scientific in\'estiga-
tions in laboratnn animals has not been applied 
to practical attempts at prevention uf contact 
sensitization in man . Principal among them are 
ethical considerations in the field of human ex-
perimentation and the lnck of a suitable model 
substance. Such a model substance should be ll 
clinically U!:ieful as a topical therapeutic agent. ~) 
capable of inducing a significant incidence of al-
lergic contact sensitization when applied topi-
cally. and 3) toxitologically and immunologically 
··safe" when admmistered intravenously or nralh 
in man. 
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The reports by Epstein and Ugel (8) and 
Mandy. Taylor and Halprin (9) showing that ni -
trogen mustard (mechlorethamine) is topically 
effective in the treatment of some t'ases of pso-
nasi!,, but lrequently induces allergit' contact sen-
Sit izatlon, suggested the possibility of practical 
application of the principle of induction of spe-
cific im munolo!{ie tolerance for the purpose of 
preventing allerJ!ic eontact sensiti7.atinn. 
The fact that nitrogen mustards are potential 
tontact allergens has been known for many years. 
Goldman and Mc:--rarv ( 10) deliberately induced 
allergic wntact sensitization to /3. !3' ,{3" trirhloro-
triethvlamine and 1'\exmand (lll to mechlore-
thamine (methyl -his ({:1-chlorethyl)amine hy-
drochloride) . It is noteworthy that apparently 
during World War II no allergic contact sensitiza-
tions to nitrogen mustard were noted by Amer-
ican inve~tigators of this potential chemical war-
fare al{ent (1~). The fact that the nitrogen mus-
tard mechlorethamine is a relatively potent con-
tact allerj!en became e\'ident. howe,·er, as soon as 
it was used in topical therapy ( 13). Sipos ( 1:3) re-
ported ~ensitization to nitrogen mustard in 3 of 7 
patients w1th mycosis fungoides. Madison and 
Haserick (I I) reported sensitization lo this com-
pound in 4 of 29 patients with various skin dis-
eases and. among these. in 3 of 17 with non-lym-
phomatous disea:.es of the skin. Among others 
who reported allergic sensitization to mechlore-
thamine are Epstein and Ugel (8) in 9 ol 12 pa-
tients with psoriasis, Van Scott and Winters (li)) 
in 6 of 21 patients with mycosis fungo ides and 
Mand~. Taylor and Halprin (9) in 1 of 7 patients 
with psoriasis. 
Mechlorethamine also fulfills the other require-
ment for a trial of pre\'ention of allergic contact 
sensitwuion in man. lt has been used intrave-
nously for manv \'ears as a chemotherapeutic 
agent and 1ts ph~rmacologic and toxicologic prop-
erties have heen extensively in,·estigated. Conse-
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quentlv the appropriate du~e:- lor clinical u~e are 
known and clinical and laboratory procedures (or 
monitoring Its ad\'cr~e effects have been e!'tah· 
lished ( 16! 
On the ha!-.i!> ol thf.'~e t·unsiderattons. studies 
were desi!{l1ed to pre\ ent allergic contact ,.l.'nsit j. 
zation hv intra\enously injet•tin!{ mct·hlore-
thamine before treatmg a series ul psoriatic pa-
tients with topit'alapplit'ation~ of thi;; wmpouncl . 
MATERIALS A!\D \IF.TIIOOS 
Th~: 9 test ~ubj~:ct>. 1\ere ntttle patient> i>E'twE'en tht> 
ajles nl II and Iii \ears who had per:,1stent psnnasis All 
of them had previously received a variet\ of treatments, 
among them vnrn>us tnpicalmrdlrctml'nts, svstrrnlt' t·or 
tico~teroids, methntrexatl' and ionizing and nun inn 
17111).! radintHill thl'rtiP.' · Tht'sc forms of treatrnt>nt had 
tuilrd tn t·onsistt'nth benefit th<'st' patirnt~ or had ht>en 
dtSrontlntll'd for ntlwr rl'INms. inl'luding und~;sirahle 
side etlerts. 
J.ahllra/t)T"\ 'Wdll'·' · All suhie(t• bt'lure start nt the 
stud\ had lahoratorv t<·sts to ntle nut hematopnlelit·, 
renal and ht•pallc anomaltPs. induding the lollm\1111( 
\B\. Rl':\. FHS. s(;OT ~CiPT. LDH. A G ratio. alka· 
ltne phosphatase. unc oc1d. lultntbin. \'DRL. In a<ldi · 
tion cnmplett> hlt~·cl t·ount;. unci tests fur liver !unction 
were clom• 1n mc,.t pat it•nt- at weckh mterYol~ during 
the tnptcal trcatml·nt w1th nitrogen mustllrd, 
T11ll>rrll:l'nlt' intrat·Pnllw, inJection. On da~~ l and S, 
tht' pat i~:nt' rt•ll'il eel an 1111 ravl'nous inje<·t ion ot :1 1111! ol 
met·hlorl'thamtne m water 
Top~t·a/ ".,rmillunp" thaapeu/tc cxpo,ure.~. On cia\ 
t1 and wt•ekh th(•rt•all Pr I subu~cts rel'cil ed tllpicul 
apphcnlwns ol lrPshly prepared nitrogen mustard snlu 
11on f1U m)( 1n 100 mlol watt'f ton st>lertPd p<11d1 ul pso· 
riasis on the right siclc and of the rnnlrul sulut ion I 1\3 
tNI lCI a s\ mmctrtcall\ ~ituatrd patrh ol psoriasis on 
the lcll sidt• Apprmumatl'h' 0.01 m)( of nitrol!l'll mus -
tard was applied per squarl' inch ol skin. Anothl'r .; suh-
JI'Ch wert• l rt'ated 1dt-nttc·allv except that the\ Tl'l'l'lll·d 
dail\ lnp1cal apphnHtnns ul :W tn)( nitrngt•n mtt-~.ml 1n 
lOll ml .\pt>ruxirnuteh tHJ.l mg nt nllrogl'n must.1rd "'l" 
applied per squan• imh of skill . The ph\sletans l'llrT\ Ill!! 
out these and all otht•r top1cal applications ol nitrctgf'n 
mustard 1\nrc gimes. ,\t all limes t·are wa.o, takt!n to 
avoid exposure ol 1 he palll!nts' e.\'es and genitals ln the 
nitrogen mustnrd solutwn. \\'hent!ver pns~ihll' the 
treat I'd an· as 1\l'Tt.: l'lran~ecl "ith soup and 11ater :! tn :1 
houn. alter appht·nt inn nl thr nllrngen mustard. 
Sub.,equt•ll/ lrl'atmrnt. II tht' slle trPated 1\tth ni -
trugen mustard solut 10n shuwpd dt,.llntt tmprm·ement 
as l'nmpan•d tn thl.' t·ontrol site. additional area~ af 
lt•t·tt•d 11ith psoriasil> lt·xduding areas near the eye~ nr 
on tht• gt·nllals) were treatl'd with the n1trogen mustard 
solution. Thi,. tn•atment wa;; repeated at dailv or wE'eklv 
mtrnnJ,.. until the treated sites had riPared or unul no 
I•ITiht'r imtlrll\'l'ml'nt wa>< notNI. 
"''nMtizn/um In chlorodmt/robenzene Four suhjet·ts, 
who ga\l' thl·ir l'onsent. underwent an attPmpt 111 sensi· 
lll.llton to l,:!.l.thlorndinitrnbenlen<' (0:"\CBJ A l>en-
"l!Ling dnst• ol [)'\('R ~ r in at·etone was applied to a I 
tm·h an•u on the upper urm The acetone wa~ allm\l'd to 
l'\ilpurntt' ond the slle was lert uncovered. Fourteen 
davs nlll•r thts ~ensit11.1ng ell.pusurr. challenge te~ts were 
<·arrll'cl nut to uscl'rtatn whl'ther allergiC contact sensilt· 
1~11tnn had ot't:urrl'd. Thl'se cunsistrd of application of 
t('st dnst•s ol 0.1 0:-\('B in acetone The t~:sls '<ites 
"t•rt• lt>lt unt·m·ered lor I~ hours, oft er whil'h th~ re!'ults 
Wl'rt' reud. 
R~L!.TS 
The t herapt•ut it· re:.ults achieved arl' shown in 
the Tahle Soon after starting the treatment im 
prmcnll'nt v.as noted at the site~; treated with 
nitrogen mu~tard 111 some of the patients. There 
was denea,.t•d !-lalmg and thickening of the 
plaques. Alter short. but \·arving periods of ttme, 
hvperpigmenta!lon was noted at the nitrogen 
mustard treated s1te:-;. making it possible to 
readilv di:-;t mgu bh the!->e sites from the site;. 
treated with the control solution. 
Clin1ral C'\ idcm·e of allergic contact senslltza-
t ion wa:-; nutt•d in 1 of 9 test subjects. ln open 
patch tPsls on one square inch skin sites. patient 
(; I I refH'ted to O.O:i mg and patient P.E. to 0.001 
mg ol nitrogen mustard. In 2 other patients con· 
siderahle erythema. edema. pain and tenderness 
de\ elupt'd at tht treated sites. Skin test!> on 
normal skin were· entirely negative. The;.e reac-
t inn,.,. whil'h neres!-.ttated discontinuation of treat-
ment. were con~tdered to be 1rritant effects. In 
tlw other patients treatment was continued until 
it was dtscont inued lor reasons other than allergic 
sen!-litization. 
fhe Table also shows the results of attempts at 
>.ensitization w1th I. 2. 1.chlorodinttrobenzene. In 
all I subjects tested, the challenge exposure in-
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FAILURE TO INDUCE IMMUNE TOLERANCE. 
duced erythema and vesiculation or bulla forma-
tion, showing that one exposure to DNCB had in-
duced allergic contact sensitization. 
DISClSSION 
Our studies confirm the previous reports (8. 9) 
that toptcal appltcauon of the nitrogen mustard 
mechlorethamine IS an eflecti,•e form of treat 
ment for some cases uf chronic persistent psu 
riasis. The results obtained were good in 5. fair in 
2 and poor tn 2 of the 9 patients in our series. 
These results nre le~:;s ta\·orable than those pre-
viously reported. 
The phenomenon of specific immunologil' toler-
ance. which we attempted to induce in these 
studies, is different from that of specific desensi-
tization described hv \ValdorL Havne::. and \ 'an 
Scott ( 17). These a~thors induced. a signif1cant 
decrease in a/read) established allergic contact 
sensitivity to nitrogen mustard 111 6 of R patients 
with mycosi~ fungoide~ throuj!h intravenous ad 
ministration of nitrogen mustard. 
Our re::mlts demonstrate a failure to pre\ent the 
development of allerglt' contact sensitization to 
mtrogen mustard throuj!h its intra,·enous admm-
lstration 8 and 11 days preceding the start of the 
potentially sensitizing topical therapeutic appli-
cations. It 1s conceivable that more patients 
would have hecome sensitized to nitrogen mus 
ta rd if the\ had not re('eJved the "tolerogenic" 
intravenow; inJeCtions. Also one cannot rule out 
the possibilit v that partial tolerance may ha\·e 
been induced in some of the sub.iects. ThesP 
points could be drcided only bv studies com-
paring the incidence and degr.ee ~f contact sensi-
tization w nitrogen mu::;tard in two larger series 
of patients with and \\it hout the "lolerogenie" 
injenions. Furthermore it appears pussible thnt 
larger tolerugenll' dm•t·s of nllrogen mustard 
would have brought about different results. 
In attempting lll interpret our finding::; one 
must take note of the pronounced difference~ in 
the inctdence of contact sensitization 1o ni1rogen 
mustard reported hy others. Each ::;eries alone ts 
too small to pro\ ide statistical significance. Hm\ . 
ever. the data suggest variation::. in the inc1denre 
of allergic contact sensitization bet ween L5f'{ and 
75!(. Examples are the low incidence of I in 7 
sensitized in one series (9). where the drug was 
applied daily in low concentration ( 10 mg in fi() 
m l) and the high incidence in another series (8). 
where 9 of 12 became sensitized after weekly ap-
plications of a high concentration (50 mg in 100 
ml). In this connection it may be significant that 
the only patients in our serie!> who became sensi-
tized had both had weekly applications of hil!h 
concentrations (50 mg in 100 mll. Daily applica-
tions in low concentrations itsell mav have a to· 
!erogenic effect as compared to the application of 
a weeki~· higher dose. 
Possible explanatiOns for these discrepanctes 
include differences in the concentration of the 
solution applied. frequency ol applications. total 
dose of nitrogen mustard per application. s ize of 
the area of application. conditions of lymphatic 
dramage w regional lvmphnodes. absorption of 
the chem1cal directly into the blood stream. etc. 
The~e are 1mportant poir.ts which deserve d<· 
tailed further il1\e>-tigauon, for it is quite possible 
that other schedules could be worked out which 
might interfere w1th or inhibit allergic contact 
sem;itizut 1011 and still permit good therapeutiC 
results. The particular schedule used bv us \\Us 
based on studtes 111 laboratory animal!;. e.g. tho~e 
of Pomeranz ( IHl. Also the optimal time interval 
in man between tnlerogenic injections and cuta-
neous ;.rnsitizing exposures remains to be aster-
tained . Furthermore it should be emphasized 
that. nt least in guinea p1gs. the oral route ap-
pear::. to hr more effective than other mutes for 
tolerogentl act ion ( Hll. 
E\1~11 if it \\ere found that larger tolerogentc 
doses and d1flerent ume schedule::. and terhmc" 
fall to indue<• immune tolerance to nitrogen mus-
tard. tht>- would still not rule out the possih!litv 
that these "nme techmcs mav be effective w1th 
other hapten>-. The metaboli~· fate of the com-
pound. 1ts persistence in the blood stream and in 
tissues, its conJugation, excretion rate. etc. mav 
\\ell have an effect on 1ls tolerngenic action. 
On the basis uf these consideratwns 11 appears 
ob\ 1ous that further triab to induce specifil' 
immunologic tolerance in man must be carried 
out. It b quttl' possible that through manipulatwn 
of \artous hwtors in the route, dose, time and frc-
qucn<'y of administration of the tolerog"en and in 
the therapeutic ~chedule (e.J!. dose and frequenl·v 
of topical application;,) it may be po~sihle to work 
out a re!('imen whtch is clinically effel'llve 111 in-
ducing tolentnl·e. 
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